Impaired cardiac contraction and relaxation and decreased expression of sarcoplasmic Ca2+‐ATPase in mice lacking the CREM gene
- 15 November 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (1) , 103-105
- https://doi.org/10.1096/fj.02-0486fje
Abstract
Congestive heart failure is the common endpoint of various cardiac diseases representing a leading cause of cardiovascular mortality in Western countries. Characteristic functional alterations of the failing heart are explained by expressional changes of myocardial regulatory proteins; however, little is known about underlying mechanisms regulating cardiac gene expression in the failing heart. Here, we address the specific role of transcription factor CREM for cardiac function in CREM mutant mice with complete inactivation of the CREM gene. We show that CREM mutant mice display distinct alterations of cardiac function resembling characteristic functional defects of the failing heart. Left ventricular hemodynamic assessment of CREM mutant mice revealed impairment of both cardiac contraction and relaxation in basal state, as well as a decreased responsiveness to beta-adrenergic stimulation. The diminished cardiac contractile performance was associated with a selective down-regulation of beta1-adrenergic receptors and a decreased ventricular expression of SERCA, the Ca2+-ATPase of the sarcoplasmic reticulum. The cardiac phenotype of CREM mutant mice provides the first evidence that CREM represents an important key regulator of cardiac gene expression, which is essential for normal left ventricular contractile performance and response to beta-adrenoreceptor stimulation.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB 556 B3, SFB 556 Z2)
- Jung-Stiftung für Wissenschaft und Forschung
This publication has 30 references indexed in Scilit:
- Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart FailureJAMA, 2000
- Transcriptional regulation by cAMP in the heartMolecular and Cellular Biochemistry, 2000
- Cellular and molecular aspects of contractile dysfunction in heart failure.Cardiovascular Research, 1998
- Effects of metoprolol on myocardial β-adrenoceptors and G iα -proteins in patients with congestive heart failureEuropean Journal of Clinical Pharmacology, 1996
- The Management of Chronic Heart FailureNew England Journal of Medicine, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Survival after the onset of congestive heart failure in Framingham Heart Study subjects.Circulation, 1993
- Chronic β1‐adrenoceptor antagonist treatment sensitizes β2‐adrenoceptors, but desensitizes M2‐muscarinic receptors in the human right atriumBritish Journal of Pharmacology, 1990
- Xamoterol in severe heart failureThe Lancet, 1990
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984